Shi-long Zhong

发表

Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity that may underly population disparities in this disease

Jiangshan J. Shen, P. Sham, Xuejun Zhang, 2020, bioRxiv.

Association between polymorphisms of the renin–angiotensin system and coronary artery disease in Chinese patients with type 2 diabetes

Shi-long Zhong, Jie-ning Zhu, Z. Shan, 2012, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Influences of an NR1I2 polymorphism on heterogeneous antiplatelet reactivity responses to clopidogrel and clinical outcomes in acute ischemic stroke patients

Shi-long Zhong, Yibei Chen, Weibang Yu, 2018, Acta Pharmacologica Sinica.

Rapid determination of common mutations in glutathione S-transferase gene by PCR-based methods in healthy Chinese.

M. Huang, Shufeng Zhou, Shi-long Zhong, 2006, Clinica chimica acta; international journal of clinical chemistry.

The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement

Shi-long Zhong, Xi-yong Yu, Yuan-yuan Liu, 2011, European Journal of Clinical Pharmacology.

Genomewide Association Study Identifies Novel Genetic Loci That Modify Antiplatelet Effects and Pharmacokinetics of Clopidogrel

Shi-long Zhong, B. Zhang, L. Tang, 2017, Clinical pharmacology and therapeutics.

SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case–control study

Shi-long Zhong, W. Lai, Ju-e Liu, 2017, European Journal of Clinical Pharmacology.

Plasma miR-142 accounting for the missing heritability of CYP3A4/5 functionality is associated with pharmacokinetics of clopidogrel.

Jiyan Chen, Shi-long Zhong, Haoming Lin, 2016, Pharmacogenomics.

Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary Intervention

Jiyan Chen, Shi-long Zhong, H. Lei, 2018, Clinical Pharmacokinetics.

UGT1A1 rs4148323 A Allele is Associated With Increased 2-Hydroxy Atorvastatin Formation and Higher Death Risk in Chinese Patients With Coronary Artery Disease

Shi-long Zhong, C. Deng, Min Qin, 2021, Frontiers in Pharmacology.

Association of PON1 genotype and haplotype with susceptibility to coronary artery disease and clinical outcomes in dual antiplatelet-treated Han Chinese patients

Jiyan Chen, Shi-long Zhong, H. Lao, 2013, European Journal of Clinical Pharmacology.

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention.

Jiyan Chen, Ya‐Ling Han, Shi-long Zhong, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention

Shi-long Zhong, Jun-qing Yang, Ying-ling Zhou, 2013, Lipids in Health and Disease.

The independent contribution of miRNAs to the missing heritability in CYP3A4/5 functionality and the metabolism of atorvastatin

Jiyan Chen, Shi-long Zhong, Haoming Lin, 2016, Scientific Reports.

Digital The gut microbiome in atherosclerotic cardiovascular disease The gut microbiome in atherosclerotic cardiovascular disease

Xun Xu, Suisha Liang, Huijue Jia, 2022 .

[MicroRNAs expression in normal and dissected aortic tissue].

Shi-long Zhong, L. Xue, Jianfang Luo, 2012, Zhonghua xin xue guan bing za zhi.

Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients

Shi-long Zhong, Xi-yong Yu, Yuan-yuan Liu, 2012, Pharmacogenetics and genomics.

Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy

Ya‐Ling Han, Shi-long Zhong, C. Deng, 2018, Acta Pharmacologica Sinica.

Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease

Shi-long Zhong, Zhi-ling Zhou, Qian Zhu, 2020, Frontiers in Pharmacology.

High levels of glucose induce “metabolic memory” in cardiomyocyte via epigenetic histone H3 lysine 9 methylation

Y. Geng, Shi-long Zhong, Z. Shan, 2012, Molecular Biology Reports.

The gut microbiome in atherosclerotic cardiovascular disease

Xun Xu, Hui Zhao, Yong Hou, 2017, Nature Communications.

Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups

Jiangshan J. Shen, P. Sham, Xuejun Zhang, 2021, Nature Communications.

Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948.

Shi-long Zhong, Yao He, Tian-bao Wang, 2012, World journal of gastroenterology.

Smad3 Inactivation and MiR-29b Upregulation Mediate the Effect of Carvedilol on Attenuating the Acute Myocardium Infarction-Induced Myocardial Fibrosis in Rat

Shi-long Zhong, Z. Shan, Xi-yong Yu, 2013, PloS one.

Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.

Shufeng Zhou, S. Chan, E. Chan, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

High levels of glucose induce “metabolic memory” in cardiomyocyte via epigenetic histone H3 lysine 9 methylation

Y. Geng, Shi-long Zhong, Z. Shan, 2012, Molecular Biology Reports.

A genome-wide association study on lipoprotein (a) levels and coronary artery disease severity in a Chinese population

Shi-long Zhong, Liwen Li, Hong Yan, 2020 .

Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus.

M. Romkes, Shufeng Zhou, E. Chan, 2006, British journal of clinical pharmacology.

Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention

Shi-long Zhong, Jun-qing Yang, Ying-ling Zhou, 2013, Lipids in Health and Disease.

Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites

Hong-Shuo Sun, Shi-long Zhong, Jia-Li Li, 2018, Acta Pharmacologica Sinica.

Influences of an NR1I2 polymorphism on heterogeneous antiplatelet reactivity responses to clopidogrel and clinical outcomes in acute ischemic stroke patients

Shi-long Zhong, Jing Jin, Zi-yi Zhou, 2018, Acta Pharmacologica Sinica.